The Digital Pill: What Everyone Should Know about the Future of Our Healthcare System
Regular price
$32.00
Regular price
Sale price
$32.00
Unit price
per
Shipping calculated at checkout.
Couldn't load pickup availability
Availability:
In stock
SKU:
9781787566767
Collections:
Regular price
$32.00
Regular price
Sale price
$32.00
The Digital Pill reflects on apps and digital projects launched by pharmaceutical companies in recent years, as well as the first accreditations for digital pills already issued by recognised regulators. The Digital Pill is essential reading for anyone working in, engaged with or interested in understanding the e-health community.
Publisher: Emerald Publishing Limited
Published: 03/22/2021
Pages: 224
Weight: 1lbs
Size: 9.10h x 6.10w x 0.80d
ISBN: 9781787566767
About the Author
Elgar Fleisch co-founded the Center for Digital Health Interventions at ETH Zurich, Switzerland, focusing on creating and testing technologies and business models for digital therapeutics. His center works in close cooperation with the Geisel School of Medicine at Dartmouth, United States, and the Future Health Technologies Center in Singapore.
Christoph Franz is Honorary Professor at the University of St. Gallen, Switzerland, and pushes several digital life science projects in the framework of his role as Chairman of Roche/Genentech.
Andreas Herrmann has spent many years studying the decision-making behaviour of individuals, particularly the influence of technologies for supporting decisions made by individuals.
Publisher: Emerald Publishing Limited
Published: 03/22/2021
Pages: 224
Weight: 1lbs
Size: 9.10h x 6.10w x 0.80d
ISBN: 9781787566767
About the Author
Elgar Fleisch co-founded the Center for Digital Health Interventions at ETH Zurich, Switzerland, focusing on creating and testing technologies and business models for digital therapeutics. His center works in close cooperation with the Geisel School of Medicine at Dartmouth, United States, and the Future Health Technologies Center in Singapore.
Christoph Franz is Honorary Professor at the University of St. Gallen, Switzerland, and pushes several digital life science projects in the framework of his role as Chairman of Roche/Genentech.
Andreas Herrmann has spent many years studying the decision-making behaviour of individuals, particularly the influence of technologies for supporting decisions made by individuals.